Filing Details

Accession Number:
0001104659-21-081619
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-15 18:50:25
Reporting Period:
2021-06-11
Accepted Time:
2021-06-15 18:50:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910329 Medifast Inc MED Miscellaneous Food Preparations & Kindred Products (2090) 133714405
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289557 R Daniel Chard C/O Medifast, Inc.
100 International Drive, 18Th Floor
Baltimore MD 21202
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-11 1,847 $287.41 139,479 No 4 S Direct
Common Stock Disposition 2021-06-11 3,264 $288.21 136,215 No 4 S Direct
Common Stock Disposition 2021-06-11 1,563 $289.30 134,652 No 4 S Direct
Common Stock Disposition 2021-06-11 761 $290.88 133,891 No 4 S Direct
Common Stock Disposition 2021-06-11 201 $291.61 133,690 No 4 S Direct
Common Stock Disposition 2021-06-11 400 $293.11 133,290 No 4 S Direct
Common Stock Disposition 2021-06-14 521 $278.14 132,769 No 4 S Direct
Common Stock Disposition 2021-06-14 2,267 $279.56 130,502 No 4 S Direct
Common Stock Disposition 2021-06-14 1,907 $280.30 128,595 No 4 S Direct
Common Stock Disposition 2021-06-14 1,038 $281.44 127,557 No 4 S Direct
Common Stock Disposition 2021-06-14 303 $282.06 127,254 No 4 S Direct
Common Stock Disposition 2021-06-14 300 $283.67 126,954 No 4 S Direct
Common Stock Disposition 2021-06-14 100 $284.65 126,854 No 4 S Direct
Common Stock Disposition 2021-06-14 100 $285.74 126,754 No 4 S Direct
Common Stock Disposition 2021-06-14 100 $287.78 126,654 No 4 S Direct
Common Stock Disposition 2021-06-14 343 $289.28 126,311 No 4 S Direct
Common Stock Disposition 2021-06-14 100 $291.00 126,211 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021.
  2. This transaction was executed in multiple trades at prices ranging from $286.86 USD to $287.85 USD inclusive; the price reported above reflects theweighted average sale price.
  3. This transaction was executed in multiple trades at prices ranging from $287.86 USD to $288.53 USD inclusive; the price reported above reflects the weighted average sale price.
  4. This transaction was executed in multiple trades at prices ranging from $288.92 USD to $289.88 USD inclusive; the price reported above reflects theweighted average sale price.
  5. This transaction was executed in multiple trades at prices ranging from $290.25 USD to $291.16 USD inclusive; the price reported above reflects theweighted average sale price.
  6. This transaction was executed in multiple trades at prices ranging from $291.30 USD to $291.74 USD inclusive; the price reported above reflects theweighted average sale price.
  7. This transaction was executed in multiple trades at prices ranging from $292.67 USD to $293.32 USD inclusive; the price reported above reflects theweighted average sale price.
  8. This transaction was executed in multiple trades at prices ranging from $277.85 USD to $278.83 USD inclusive; the price reported above reflects theweighted average sale price.
  9. This transaction was executed in multiple trades at prices ranging from $278.85 USD to $279.84 USD inclusive; the price reported above reflects theweighted average sale price.
  10. This transaction was executed in multiple trades at prices ranging from $279.85 USD to $280.83 USD inclusive; the price reported above reflects theweighted average sale price.
  11. This transaction was executed in multiple trades at prices ranging from $281.00 USD to $281.94 USD inclusive; the price reported above reflects theweighted average sale price.
  12. This transaction was executed in multiple trades at prices ranging from $282.00 USD to $282.10 USD inclusive; the price reported above reflects theweighted average sale price.
  13. This transaction was executed in multiple trades at prices ranging from $283.45 USD to $284.00 USD inclusive; the price reported above reflects theweighted average sale price.
  14. This transaction was executed in multiple trades at prices ranging from $285.65 USD to $286.01 USD inclusive; the price reported above reflects theweighted average sale price.
  15. This transaction was executed in multiple trades at prices ranging from $287.68 USD to $287.89 USD inclusive; the price reported above reflects theweighted average sale price.
  16. This transaction was executed in multiple trades at prices ranging from $289.00 USD to $289.49 USD inclusive; the price reported above reflects theweighted average sale price.